These stocks have an unusual volume in today's session
By Mill Chart
Last update: Sep 26, 2022
Let's have a look at what is happening on the US markets on Monday. Below you can find the stocks with an unusual volume in today's session.
Top unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| LITM | -33.18% | SNOW LAKE RESOURCES LTD (NASDAQ:LITM) has an unusual volume of 4.21M shares. NASDAQ:LITM is declining 33.18% today. The average daily volume over 50 days is 1.76M, so this is 139.0% above the average volume. |
| NAOV | -19.39% | NANOVIBRONIX INC (NASDAQ:NAOV) has an unusual volume of 627.94K shares today. The share price decreased by 19.39%. The average volume measured over 50 days is 443.8K, so this is 41.49% above the average volume. |
| SONX | -6.69% | SONENDO INC (NYSE:SONX) has an unusual volume of 745.29K shares. Shares are falling by 6.69%. This is 62.7% above the average daily volume of the last 50 days. |
| ISPC | 13.6% | 13.41M shares of ISPECIMEN INC (NASDAQ:ISPC) exchanged hands today. Leading to a price increase of 13.6%. This is 12.0K% above the average daily volume of the last 50 days. |
| MDGS | -5.89% | So far 379.32K shares of MEDIGUS LTD - SPON ADR (NASDAQ:MDGS) have traded in today's session. The share price decreased by 5.89%. This volume is 183.0% above the average 50 day volume. |
| FENC | -11.24% | FENNEC PHARMACEUTICALS INC (NASDAQ:FENC) has an unusual volume of 264.72K shares today. Shares are falling by 11.24%. This is 101.0% above the average daily volume of the last 50 days. |
| SPRO | 2.28% | SPERO THERAPEUTICS INC (NASDAQ:SPRO) has an unusual volume of 10.64M shares. The share price increased by 2.28%. The average volume measured over 50 days is 8.53M, so this is 24.79% above the average volume. |
| TPGY | -0.1% | 911.0K shares of TPG PACE BENEFICIAL FIN-CL A (NYSE:TPGY) have been traded so far today. NYSE:TPGY is declining 0.1% today. The average volume measured over 50 days is 145.45K, so this is 526.0% above the average volume. |
| CCVI | 0.02% | 564.65K shares of CHURCHILL CAPITAL CORP VI-A (NYSE:CCVI) have been traded so far today. Shares are rising by 0.02%. This is 313.0% above the average daily volume of the last 50 days. |
| SAI | -9.09% | SAITECH GLOBAL CORP's (NASDAQ:SAI) traded a high volume of 225.08K shares. Shares are falling by 9.09%. The average daily volume over 50 days is 181.02K, so this is 24.34% above the average volume. |
For the full unusual volume stocks list go to our unusual volume stocks screener.
SPERO THERAPEUTICS INC
NASDAQ:SPRO (4/15/2024, 7:00:02 PM)
Premarket: 1.5706 +0.04 (+2.65%)1.53
-0.11 (-6.71%)
SPRO News
a month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start the day with a breakdown of all the biggest pre-market stock movers worth watching on Thursday morning!
On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected...
CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical...
CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
In 2H 2024, expect to provide Phase 2a topline proof-of-concept data from our wholly-owned lead program SPR720 in NTM-PD patients
$95 million in development milestones payable over two years, as part of GSK license agreement...
6 months ago - Bragar Eagel & Squire, P.C.SPERO ALERT: Bragar Eagel & Squire, P.C. is Investigating Spero Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
